Abstract
AbstractPrognosis after neoadjuvant chemotherapy (NAC) for osteosarcoma is generally predicted using manual necrosis-rate assessments; however, necrosis rates obtained in these assessments are not reproducible and do not adequately reflect individual cell responses. We aimed to investigate whether viable tumor cell density assessed using a deep-learning model (DLM) reflects the prognosis of osteosarcoma. Seventy-one patients were included in this study. Initially, the DLM was trained to detect viable tumor cells, following which it calculated their density. Patients were stratified into high and low-viable tumor cell density groups based on DLM measurements, and survival analysis was performed to evaluate disease-specific survival and metastasis-free survival (DSS and MFS). The high viable tumor cell density group exhibited worse DSS (p = 0.023) and MFS (p = 0.033). DLM-evaluated viable density showed correct stratification of prognosis groups. Therefore, this evaluation method may enable precise stratification of the prognosis in osteosarcoma patients treated with NAC.
Funder
MEXT | Japan Society for the Promotion of Science
Research funds of Graduate School of Medical Sciences, Kyushu University
Publisher
Springer Science and Business Media LLC
Reference34 articles.
1. WHO. WHO Classification of Tumours of Soft Tissue & Bone. 5th edn. The WHO classification of tumours editorial board (eds) (WHO, Lyon, France, 2020).
2. Anninga, J. K. et al. Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand? Eur. J. Cancer 47, 2431–2445 (2011).
3. Chou, A. J., Geller, D. S. & Gorlick, R. Therapy for osteosarcoma: where do we go from here? Paediatr. Drugs 10, 315–327 (2008).
4. Kager, L. et al. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J. Clin. Oncol. 21, 2011–2018 (2003).
5. Zhong, J. et al. A systematic review of radiomics in osteosarcoma: utilizing radiomics quality score as a tool promoting clinical translation. Eur. Radiol. 31, 1526–1535 (2021).